Introduction
Pyrazolines show a variety of biological activities. They are antimicrobial [1] [2] [3] [4] , antifungal [5] , anti-depressant [6] , immunosuppressive [7] , anticonvulsant [8] [9] [10] , antitumor [11] , anti-amoebic [12] , antibacterial [13] , antiinflammatory [14] , anticancer [15] , and MAO inhibitory activity [16] . Hydrazonoyl halides have been widely used as reagents for the synthesis of various heterocyclic compounds [17, 18] . Thiazoles are used in drugs developed for the treatment of allergies [19] , hypertension [20] , inflammation [21] , schizophrenia [22] , bacterial infections [23] , HIV [24] , sleep disorders [25] and more recently, for the treatment of pain [26] . They are also used as fibrinogen receptor antagonists with antithrombotic activity [27] , and as new inhibitors of bacterial DNA gyrase B [28] . Moreover, 1,3,4-thiadiazoles are among the most common heterocyclic pharmacophores. They display a broad spectrum of biological activities, including antimicrobial [29] , anticancer [30, 31] , antioxidant [32] , anti-depressant [33] , anticonvulsant [34, 35] and antihypertensive activities [36] , as well as acetyl cholinesterase inhibition for the treatment of Alzheimer's disease [37, 38] . In continuation of the author's research work [39] [40] [41] [42] [43] [44] [45] , the synthesis of some new thiazoles, 1,3,4-thiadiazoles and pyrano [2,3- 
Results and discussion
The reaction of 5-(furan-2-yl)-3-(p-tolyl)-4,5-dihydro-1H-pyrazole-1-carbothioamide (1) with ethyl 2-chloro-3-oxobutanoate, ethyl 2-chloroacetate or 3-chloropentane-2,4-dione in ethanol containing an amount of triethylamine afforded ethyl 2-(5-(furan-2-yl)-3-(p-tolyl)-4,5-dihydro-1H-pyrazol-1-yl)-4-methylthiazole-5-carboxylate (2), 2-(5-(furan-2-yl)-3-(p -tolyl)-4,5-dihydro-1H -py ra zol-1-yl) thiazol-4(5H)-one (3) and 1-(2-(5-(furan-2-yl)-3-(ptolyl)-4,5-dihydro-1H-pyrazol-1-yl)-4-methylthiazol-5-yl)ethan-1-one (4), respectively (Scheme 1).
The structures of the compounds (2-4) were clarified by elemental analyses, FTIR, MS, NMR spectra and chemical transformation. Compound (2) reacted with hydrazine hydrate to afford 2-(5-(furan-2-yl)-3-(p-tolyl)-4,5-dihydro-1H-pyrazol-1-yl)-4-methylthiazole-5-carbohydrazide (5) (Scheme 2). The structure of compound (5) was elucidated by elemental analyses, spectral data, and chemical transformations. Compound (5) reacted with nitrous acid, potassium thiocyanate, 3-(2-arylhydrazono)pentane-2,4-dione (8a and 8b) or ethyl 2-(2-arylhydrazono)-3-oxobutanoate (9a and 9b) to afford the following: 2-(5-(furan-2-yl)-3-(p-tolyl)-4,5-dihydro-1H-pyrazol-1-yl)-4-methylthiazole-5-carbonyl azide (6), 2-(2-(5-(furan-2-yl)-3-(p-tolyl)-4,5-dihydro-1H-pyrazol-1-yl)-4-methylthiazole-5-carbonyl)hydrazine-1-carbothioamide (7), (3,5-dimethyl-4-(phenyldiazenyl)-1H-pyrazol-1-yl) (2-(5-(furan-2-yl)-3-(p-tolyl)-4,5-dihydro-1H-pyrazol-1-yl)-4-methylthiazol-5-yl)methanone (10a), (3,5-dimethyl -4 -(p-tolyldiazenyl)-1H-pyrazol-1-yl)(2-(5-(furan -2-yl)-3-(p-tolyl)-4,5-dihydro-1H-pyrazol-1-yl)-4-methylthiazol-5-yl)methanone (10b), 2-(2-(5-(furan-2-yl)-3-(p-tolyl)-4,5-dihydro-1H-pyrazol-1-yl)-4-methylthiazole-5-carbonyl)-5-methyl-4-(2-phenylhydrazono)-2,4-dihydro-3H-pyrazol-3-one (11a) and 2-(2-(5-(furan -2-yl)-3-(p-tolyl)-4,5-dihydro-1H-pyrazol-1-yl)-4-methylthiazole-5-carbonyl)-5-methyl-4-(2-(p-tolyl) hydrazono)-2,4-dihydro-3H-pyrazol-3-one (11b), respectively (Scheme 2). The structures of compounds (6, 7, 10a and 10b) and (11a and 11b) were confirmed by elemental analyses, spectral data and chemical transformations whenever possible.
Treatment of 2-(5-(furan-2-yl)-3-(p-tolyl)-4,5-dihydro-1H-pyrazol-1-yl)-4-methylthiazole-5-carbonyl azide (6) with aniline, 4-toluidine or anthranilic acid in boiling (13) , respectively. Also, compound (6) reacted with 2-naphthol in boiling benzene to afford naphthalen-2-yl(2-(5-(furan-2-yl)-3-(p-tolyl)-4,5-dihydro-1H-pyrazol-1-yl)-4-methylthiazole-5-carboxylate (14) (Scheme 3). The structures of compounds (12) (13) (14) were confirmed by elemental analyses, spectral data and an alternative synthetic route. Thus, compound (6) reacted with methyl anthranilate in dioxane to afford a product identical in all aspects (mp, mixed mp and spectra) to compound (13) . (15) . The latter reacted with the appropriate hydrazonoyl halides (16a-d) in refluxing chloroform in the presence of triethylamine to give
The mechanism outlined in Scheme 4 seemed to be the most plausible pathway for the formation of (20) from the reaction of (15) or (15a) with (16) by two possible pathways. The first pathway was via 1,3-addition of the thiol tautomer (15) to the nitrilimine (19a-d) (which produced in situ from the reaction of hydrazonoyl halide [16a-d] with triethylamine) to give the thiohydrazonate ester (17) that underwent nucleophilic cyclization to yield spiro compound (18) . The latter underwent ring opening and cyclization to yield (20) . The second pathway was via 1,3-cycloaddition of nitrilimine (19) to the C=S double bond of (15a) to give (18) directly (Scheme 4). Attempts to isolate the thiohydrazonate ester (17) or the intermediate (18) did not succeed, even under mild conditions, as these two compounds readily underwent in situ cyclization to give the final isolable product (20) , as shown in Scheme 4.
Treatment of 2-(2-(5-(furan-2-yl)-3-(p-tolyl)-4,5-dihydro-1H-pyrazol-1-yl)-4-methylthiazole-5-carbonyl) hydrazine-1-carbothioamide (7) with the appropriate hydrazonoyl halides (16b) and (16c) in ethanolic triethylamine afforded 2-
respectively (Scheme 5). The structures of compounds (21a and 21b) were confirmed by elemental analyses and spectral data. On the other hand, the treatment of compound (5) with maleic anhydride and phthalic anhydride afforded (23) , respectively (Scheme 6). The structures of compounds (22) and (23) were elucidated by elemental analyses and spectral data (cf. Experimental).
Finally, treatment of 2-(5-(furan-2-yl)-3-(p-tolyl)-4,5-dihydro-1H-pyrazol-1-yl)thiazol-4(5H)-one (3) with arylidenemalononitriles (24a-c) in boiling ethanol containing a catalytic amount of piperidine afforded
The structures of compounds (25a-c) were elucidated by elemental analyses, spectral data and a synthetic route. Thus, the infrared (IR) spectrum of compound (25a) showed bands at 3388 and 3175 cm −1 , Scheme 1 Synthesis of compounds (2) (3) (4) which corresponded to the NH 2 group. Furthermore, a mixture of malononitrile, an appropriate aldehyde and 2-(5-(furan-2-yl)-3-(p-tolyl)-4,5-dihydro-1H-pyrazol-1-yl)thiazol-4(5H)-one (3) in ethanol containing a few drops of piperidine as a catalyst was heated under reflux to afford products identical in all aspects (mp, mixed mp and spectra) with (25a-c), respectively (Scheme 7). According to these results, we can suggest the following structure activity relationships:
Antimicrobial activity
A. In the thiazoles (3), (4) , and (14) (1) Attachment of C 10 H 7 OCO group in (14) at position 5 in the thiazole ring is very important for antimicrobial activity and increases the activity towards Gram-negative bact. (2) Attachment of H or CH 3 CO group at position 5 in the thiazole ring showed a moderate antimicrobial activity for all microorganisms in Table 1 .
B. In the thiazolyluera (12a) and (12b)
(1) Attachment of PhNHCONH or 4-CH 3 C 6 H- 4 NHCONH group in (12a) or (12b) at position 5 in the thiazole ring showed a moderate antimicrobial activity for all microorganisms in Table 1 .
C. In the thiazolylpyrazoles 10, 11(a-b)
(1) Attachment of methyl and -N=NPh groups in (10a) and attachment of OH and -N=NPh groups in (11b) at positions 3, 4 respectively, in the moiety of the pyrazole ring had no activity against all the tested Gram-positive and Gramnegative bact. but had moderate activity against test fungi. D. In the thiazolylquinazolinedione (13) (1) Attachment of quinazoline-2,4(1H,3H)-dione ring at position 5 in the thiazole ring showed a moderate antimicrobial activity for all microorganisms in Table 1 .
E. In the thiazolyloxadiazole (15) (1) Attachment of 1,3,4-oxadiazole-2-thiole ring at position 5 in the thiazole ring showed a moderate antimicrobial activity for all microorganisms in Table 1 .
Scheme 4 Synthesis of compounds (15) and (20a-d) Abdelhamid et al. BMC Chemistry (2019) 13:48

Scheme 5 Synthesis of compounds (21a and 21b)
Scheme 6 Synthesis of compounds (22) and (23) Scheme 7 Synthesis of compounds (25a-c) (1) Attachment of CH 3 -group in (21a) at position 4 in the moiety of the thiazole ring displayed a moderate antimicrobial activity for all microorganisms in Table 1 . (2) Attachment of C 6 H 5 -group in (21b) at position 4 in the moiety of the thiazole ring displayed a moderate antimicrobial activity for all microorganisms in Table 1 except PA which has no activity.
H. In the thiazolylpyridazine-3,6-dione (22) Attachment of carbonyl-1,2-dihydropyridazine-3,6-dione group at position 5 in the thiazole ring displayed potent effect against fungi and a moderate activity against Gram-positive bact., and Gram-negative bact. except PA which has no activity. I. In the thiazolylphthalazine-1,4-dione (23) Attachment of carbonyl-2,3-dihydrophthalazine-1,4-dione group at position 5 in the thiazole ring showed a moderate antimicrobial activity for all microorganisms in Table 1 
Experimental
General information
An electrothermal device (Bibby Sci. Lim. Stone, Staffordshire, UK) has been used to determine all melting points and they are uncorrected. A FT-IR 8201 PC spectrophotometer (Shimadzu, Tokyo, Japan) was used to determine the IR spectra. On Varian Mercury VX-300 NMR spectrometer (Varian, Inc., Karlsruhe, Germany) operating at 300 MHz ( 1 H NMR), the 1 H-NMR spectra were recorded in CDCl 3 and DMSO-d 6 solutions. The chemical shifts are expressed in δ ppm units using TMS as an internal reference. On a Shimadzu GC-MS QP1000 EX instrument (Tokyo, Japan) mass spectra were recorded. Elemental analyses were performed at the University of Cairo's Microanalytical Center. As previously reported, hydrazonoyl halides [46] [47] [48] [49] and 5-(furan-2-yl)-3-(p-tolyl)-4,5-dihydro-1H-pyrazole-1-carbothioamide [39] Additional file 1: Figure S1 were prepared. In the Regional Center for Mycology and Biotechnology, AlAzhar University, Cairo, Egypt, antimicrobial screening was conducted.
Compounds (2-4)
General procedure
A mixture of compound (1) (2.85 g, 5 mmol), and the appropriate halogenated reagents (ethyl 2-chloro-3-oxobutanoate, ethyl 2-chloroacetate, or 3-chloropentane-2,4-dione) (10 mmol) in ethanol (20 mL) containing a catalytic amount of triethylamine was refluxed for 2 h.
The reaction mixture was left to cool to room temperature. The formed solid was filtered off, dried, and recrystallized from an appropriate solvent to obtain the corresponding compounds (2-4), respectively.
Compound (2) Figure S5 A mixture of ethyl 2-(5-(furan-2-yl)-3-(p-tolyl)-4,5-dihydro-1H-pyrazol-1-yl)-4-methylthiazole-5-carboxylate (2) (3.95 g, 10 mmol), and hydrazine hydrate (20 mL) was heated under reflux for 12 h. The reaction mixture was left to cool to room temperature. The formed precipitate was filtered off, washed with ethanol, and recrystallized from glacial acetic acid to obtain compound (5) 
Compound (5). Additional file 5:
Compound (7). Additional file 7: Figure S7
Compounds (10a, b) and (11a, b), General procedure
A mixture of 2-(5-(furan-2-yl)-3-(p-tolyl)-4,5-dihydro-1H-pyrazol-1-yl)-4-methylthiazole-5-carbohydrazide (5) (3.81 g, 10 mmol), and the appropriate amount of 3-(2-arylhydrazono)pentane-2,4-dione or ethyl 3-oxo-2-(2-arylhydrazono)butanoate (10 mmol) in acetic acid (20 mL) was heated under reflux for 2 h. The reaction mixture was left to cool to room temperature. The formed solid was filtered off, dried, and recrystallized from an appropriate solvent to obtain the corresponding compounds (10a, 10b, 11a, and 11d) , respectively. Figure S8 Yellow solid from glacial acetic acid, yield (3.90 g, 71%), mp: 234-235 °C; IR (KBr, cm 12a and 12b), and (13) , general procedure A mixture of 2-(5-(furan-2-yl)-3-(p-tolyl)-4,5-dihydro-1H-pyrazol-1-yl)-4-methylthiazole-5-carbonyl azide (6) (2.2 g, 5 mmol) and the appropriate amount of aromatic amines (aniline, 4-methylaniline), anthranilic acid or methyl anthranilate (5 mmol) in dioxane (20 mL), was heated under reflux for 3 h. The reaction mixture was left to cool to room temperature. The formed solid formed was filtered off, dried, and recrystallized from an appropriate solvent to obtain the corresponding compounds (12a), and (12b), and (13) Compound (15) . Additional file 16: Figure  S16 2-(5-(Furan-2-yl)-3-(p-tolyl)-4,5-dihydro-1H-pyrazol-1-yl)-4-methylthiazole-5-carbohydrazide (3.81 g, 10 mmol) was suspended in ethanol, and then carbon disulfide (10 mL) was added, dropwise, to the suspension at 5-10 °C. The mixture was heated for 10 h under reflux in the presence of potassium hydroxide (0.56 g, 10 mmol). The solution was cooled and acidified to pH 5-6 using HCl solution, and the formed solid was collected and recrystallized to obtain a yellow solid from dioxane, yield (3. 
Compound (10a). Additional file 8:
Compounds (21a) and (21b), general procedure
A mixture of 2-(2-(5-(furan-2-yl)-3-(p-tolyl)-4,5-dihydro-1H-pyrazol-1-yl)-4-methylthiazole-5-carbonyl) hydrazinecarbothioamide (7) (2.20 g, 5 mmol), and the appropriate hydrazonoyl halides (16b and 16c) (5 mmol), in ethanol (20 mL) containing a catalytic amount of triethylamine was heated under reflux for 2 h. The reaction mixture was left to cool to room temperature. The formed solid was filtered off, dried, and recrystallized from glacial acetic acid to obtain compounds (21a), and (21b), respectively. 
Compound (21a
Compounds (22) and (23), general procedure
A mixture of 2-(5-(furan-2-yl)-3-(p-tolyl)-4,5-dihydro-1H-pyrazol-1-yl)-4-methylthiazole-5-carbohydrazide (5) (1.95 g, 5 mmol), and the appropriate maleic anhydride or phthalic anhydride (5 mmol) was heated under reflux in glacial acetic acid for 2 h. The reaction mixture was left to cool to room temperature. The formed solid was filtered off, dried, and recrystallized from acetic acid to obtain compounds (22) and (23), respectively.
Compound (22) 
Compounds (25a-c), general methods
Method A A mixture of 2-(5-(furan-2-yl)-3-(p-tolyl)-4,5-dihydro-1H-pyrazol-1-yl)thiazol-5(4H)-one (2) (1.6 g, 5 mmol), and the appropriate arylidenemalononitrile (24a-c) in ethanol (20 mL) containing a catalytic amount
